SEGMENT INFORMATION

3 Months Ended

Mar. 31, 2025

SEGMENT INFORMATION

SEGMENT INFORMATION

21.     SEGMENT INFORMATION

Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company currently operates in one business segment focused on the sale and delivery of TMS products and clinical services that improve the quality of life for people suffering from neurohealth disorders. The Company’s CODM is the chief executive officer.

The accounting policies of the Company’s segment are the same as those described in the summary of significant accounting policies. The key measure of segment profit or loss that the CODM uses to allocate resources and assess performance is the Company’s net loss from operations, as reported on the accompanying statements of operations. The measure of segment assets is reported on the balance sheets as total consolidated assets with particular emphasis on the Company’s available liquidity, including its cash and cash equivalents and restricted cash.

The following table illustrates information about reported segment revenue, measures of a segment’s profit or loss, significant segment expenses, and measure of a segment's assets for the current reporting period.

	Three months ended March 31,
	2025		2024
Revenue	$	31,975	$	17,417
Cost of revenues		16,237		4,329
Segment Gross profit	$	15,738	$	13,088
Personnel	$	17,676	$	12,138
Marketing		2,937		2,228
Research and development		255		800
Professional fees		1,445		1,103
Other segment expenses (a)		4,440		3,678
Segment Loss	$	(11,014)	$	(6,859)
Unallocated
Interest expense		1,922		1,826
Other income,net	$	(247)		(812)
Net Loss	$	(12,689)	$	(7,873)

(a) Other segment expenses include travel and entertainment, bad debt, depreciation and amortization, insurance, rent, and other costs.